[Analysis of national leprosy surveillance data in Mauritania from 2009 to 2019].
Analyse des données nationales de surveillance de la lèpre en Mauritanie de 2009 à 2019.
Disease control programme
Epidemiology
Leprosy
Mauritania
Northwest Africa
Journal
Medecine tropicale et sante internationale
ISSN: 2778-2034
Titre abrégé: Med Trop Sante Int
Pays: France
ID NLM: 9918227363206676
Informations de publication
Date de publication:
30 06 2023
30 06 2023
Historique:
received:
27
10
2022
accepted:
27
03
2023
medline:
2
8
2023
pubmed:
1
8
2023
entrez:
1
8
2023
Statut:
epublish
Résumé
Leprosy is a chronic infectious disease that mainly affects the skin, mucous membranes and the peripheral nervous system. Its elimination as a public health problem seems to lead to its ignorance and therefore to a risk of late diagnosis. An analysis of leprosy surveillance data in Mauritania was conducted to determine epidemiological trends and clinical forms of reported cases. The retrospective study was based on the epidemiological records of leprosy in Mauritania from 2009 to 2019. The diagnosis of leprosy was made on the basis of the diagnostic criteria of the World Health Organization (WHO). Data were analyzed using Epi Info version 7.2.5.0. The frequencies, proportions, and rates were calculated. Over the past 11 years, 164 cases have been notified. Among the notified cases, 96/164 (58.5%) were males and 68/164 (41.5%) females, with a sex ratio of 1.4. The mean age (± standard deviation) was 44.0 ± 17.1 years [range, 9 - 86 years], and the median was 45 years [interquartile range, 32.5; 57.5]. Children under the age of 16 accounted for 9/164 (5.5%). The wilayas (i.e. "regions") of Nouakchott were the most endemic regions in the country. The multibacillary form (MB) represented 109/164 (66.5%) cases among the observed clinical forms. The average annual incidence was 0.3 case/100,000 population for MB and 0.1 case/100,000 for PB (paucibacillary). All reported cases were treated with multidrug therapy. The results of leprosy surveillance showed a persistence of this disease in Mauritania. It is necessary to relaunch leprosy services at all levels in order to continue to reduce the morbidity associated with this disease, and eventually eliminate it from the country.
Identifiants
pubmed: 37525686
doi: 10.48327/mtsi.v3i2.2023.361
pmc: PMC10387306
pii:
doi:
Substances chimiques
Leprostatic Agents
0
Types de publication
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2023 SFMTSI.
Références
J Am Acad Dermatol. 2020 Jul;83(1):1-14
pubmed: 32229279
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1205-1213
pubmed: 30945360
Bull Soc Pathol Exot. 2018;111(2):99-103
pubmed: 30789236
Med Trop (Mars). 2008 Feb;68(1):33-7
pubmed: 18478769
Med Mal Infect. 2005 Apr;35(4):225-7
pubmed: 15914293
Ann Dermatol Venereol. 2001 Mar;128(3 Pt 1):217-9
pubmed: 11319383
BMC Public Health. 2020 Aug 18;20(1):1254
pubmed: 32811449
Glob Health Action. 2016 Nov 23;9:32962
pubmed: 27885973